Lymphoma
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Biology and Treatment of LGL Leukemia
FEATURING
Thomas Loughran
- 166 views
- October 17, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Hodgkin Lymphoma
FEATURING
Nancy Bartlett
- 239 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Next Questions: Mantle Cell Lymphoma
FEATURING
Kami Maddocks
- 71 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: T-Cell Lymphoma
FEATURING
Swaminathan Iyer
- 44 views
- October 14, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Follicular Lymphoma
FEATURING
Gilles Salles
- 79 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?
FEATURING
Laurie H. Sehn
- 456 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Cellular Therapy
FEATURING
Krishna Komanduri
- 190 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro AUTO HCT
FEATURING
Craig Sauter
- 29 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro CAR T-Cell
FEATURING
Manali Kamdar
- 49 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Camidanlumab Tesirine - Updated Efficacy and Safety in Patients With R/R cHL
FEATURING
Alex Herrera
- 27 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Treating Hodgkin Lymphoma After Brentuximab Vedotin and Anti-PD1 Failure
FEATURING
Alex Herrera
- 149 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Treatment of Hodgkin Lymphoma
FEATURING
Alison Moskowitz
- 235 views
- October 14, 2022
- 1
SOHO 2022 Tenth Annual Meeting
Phase 1/2 BRUIN Study - Updated Results on Pirtobrutinib in Previously Treated MCL
FEATURING
Jonathon Cohen
- 118 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Emerging Treatment Options for MCL
FEATURING
Jia Ruan
- 57 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Immunotherapeutic Options for Patients With MCL Who Progress on BTK Inhibitors
FEATURING
Jonathon Cohen
- 80 views
- October 14, 2022
- 1
Tycel Phillips
The Role of Targeted Therapies in Frontline Treatment of MCL
- 127 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Is it Time to Recognize the Biological Heterogeneity of MCL?
FEATURING
Andre Goy
- 82 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated DLBCL
FEATURING
John Burke
- 27 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Managing the Elderly Patient With Aggressive B-cell Lymphoma in The Modern Era
FEATURING
Catherine Thieblemont
- 29 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CNS Prophylaxis in DLBCL
FEATURING
Victor Orellana-Noia
- 54 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Treatment of Aggressive B-cell Lymphoma Post-CAR T-Cell Therapy
FEATURING
Grzegorz Nowakowski
- 25 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Choosing CAR T-Cell Therapy vs. ASCT in R/R Aggressive B-cell Lymphoma
FEATURING
Manali Kamdar
- 159 views
- October 14, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Has R-CHOP Really Been Replaced as Initial Therapy of DLBCL?
FEATURING
Jonathan Friedberg
- 996 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Using Biology to Determine Type and Duration of Treatment in Waldenstrom Macroglobulinemia
FEATURING
Prashant Kapoor
- 18 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Future Role of Bispecific Antibodies in the Treatment of Follicular Lymphoma
FEATURING
Elizabeth Budde
- 32 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: What Is the Role of Transplantation for FL in the Era of CAR T-cell Therapy?
FEATURING
Mehdi Hamadani
- 20 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choices
FEATURING
Loretta Nastoupil
- 277 views
- October 14, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Advances in the Treatment of NK/T Cell Lymphoma
FEATURING
Won Seog Kim
- 30 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous T-cell Lymphoma
FEATURING
Pamela Allen
- 76 views
- October 14, 2022
- 2
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Novel Treatment Approaches in Relapsed/Refractory PTCL
FEATURING
Matthew Lunning
- 14 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: The Next Rational Therapeutic Regimen in Newly Diagnosed PTCL
FEATURING
Neha Mehta-Shah
- 28 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: From Bench to Bedside - A Translational Scientist's Perspective on How to Transform PTCL Outcome
FEATURING
Francisco Vega
- 20 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas
FEATURING
Jeremy Abramson
- 87 views
- October 13, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas
FEATURING
Stefan Barta
- 22 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymphoma
FEATURING
Christian Steidl
- 79 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma
FEATURING
Carlos Ramos
- 22 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: The Next Generation of Novel Agents in Development for Aggressive B-Cell Lymphoma
FEATURING
Jason Westin
- 238 views
- October 13, 2022
- 5